| 1 | Amgen Inc | AMGN:US | Health Care | $38.1B | 25.8 | $224.3B |
| 2 | Gilead Sciences Inc | GILD:US | Health Care | $30.5B | - | $187.4B |
| 3 | Intuitive Surgical Inc | ISRG:US | Health Care | $11.0B | 47.6 | $149.8B |
| 4 | Vertex Pharmaceuticals Inc | VRTX:US | Health Care | $12.6B | 29.7 | $129.3B |
| 5 | Sanofi ADR | SNY:US | Health Care | $48.9B | 21.2 | $96.0B |
| 6 | Moderna Inc | MRNA:US | Health Care | $2.2B | - | $85.3B |
| 7 | Regeneron Pharmaceuticals Inc | REGN:US | Health Care | $15.5B | 18.5 | $76.9B |
| 8 | Natera Inc | NTRA:US | Health Care | $2.7B | - | $57.8B |
| 9 | argenx NV ADR | ARGX:US | Health Care | $5.3B | 31.4 | $51.9B |
| 10 | Medline Inc. Class A Common Stock | MDLN:US | Health Care | $29.9B | 90.7 | $48.8B |
| 11 | Agilent Technologies Inc | A:US | Health Care | $7.4B | 29.7 | $43.3B |
| 12 | Illumina Inc | ILMN:US | Health Care | $4.5B | 51.6 | $41.8B |
| 13 | IDEXX Laboratories Inc | IDXX:US | Health Care | $4.6B | 36.4 | $40.8B |
| 14 | Revolution Medicines Inc | RVMD:US | Health Care | $742,000 | - | $40.7B |
| 15 | BeiGene, Ltd. | ONC:US | Health Care | $6.1B | 62.7 | $39.9B |
| 16 | Biogen Inc | BIIB:US | Health Care | $10.0B | 40.7 | $33.9B |
| 17 | Royalty Pharma Plc | RPRX:US | Health Care | $2.5B | 30.3 | $32.9B |
| 18 | DexCom Inc | DXCM:US | Health Care | $5.0B | 34.1 | $32.4B |
| 19 | Alnylam Pharmaceuticals Inc | ALNY:US | Health Care | $4.8B | 39.2 | $31.1B |
| 20 | GE HealthCare Technologies Inc. | GEHC:US | Health Care | $21.3B | 15.6 | $30.8B |
| 21 | Roivant Sciences Ltd | ROIV:US | Health Care | $8M | - | $25.6B |
| 22 | BioNTech SE | BNTX:US | Health Care | $2.6B | - | $24.4B |
| 23 | United Therapeutics Corporation | UTHR:US | Health Care | $3.2B | 19.7 | $23.6B |
| 24 | Genmab AS | GMAB:US | Health Care | $4.1B | 29.4 | $23.0B |
| 25 | Incyte Corporation | INCY:US | Health Care | $5.8B | 14.4 | $22.9B |
| 26 | Guardant Health Inc | GH:US | Health Care | $1.2B | - | $21.8B |
| 27 | Insmed Inc | INSM:US | Health Care | $1.1B | - | $21.5B |
| 28 | Viatris Inc | VTRS:US | Health Care | $14.7B | - | $20.3B |
| 29 | Medpace Holdings Inc | MEDP:US | Health Care | $2.8B | 35.9 | $17.1B |
| 30 | Ascendis Pharma AS | ASND:US | Health Care | $1.0B | 17.6 | $15.1B |
| 31 | Exelixis Inc | EXEL:US | Health Care | $2.4B | 18.9 | $14.8B |
| 32 | Neurocrine Biosciences Inc | NBIX:US | Health Care | $3.4B | 20.7 | $14.4B |
| 33 | Jazz Pharmaceuticals PLC | JAZZ:US | Health Care | $4.6B | 15.0 | $14.2B |
| 34 | Summit Therapeutics PLC | SMMT:US | Health Care | - | - | $14.0B |
| 35 | Corcept Therapeutics Incorporated | CORT:US | Health Care | $831M | 269.3 | $13.1B |
| 36 | BridgeBio Pharma Inc | BBIO:US | Health Care | $713M | - | $12.8B |
| 37 | ICON PLC | ICLR:US | Health Care | $8.3B | 172.8 | $12.7B |
| 38 | Halozyme Therapeutics Inc | HALO:US | Health Care | $1.7B | 32.3 | $12.5B |
| 39 | BrightSpring Health Services, Inc. Common Stock | BTSG:US | Health Care | $14.4B | 55.8 | $12.5B |
| 40 | Tempus AI, Inc. Class A Common Stock | TEM:US | Health Care | $1.4B | - | $12.3B |
| 41 | Bio-Techne Corp | TECH:US | Health Care | $1.2B | 62.5 | $11.4B |
| 42 | Vaxcyte Inc | PCVX:US | Health Care | - | - | $11.2B |
| 43 | Immunitybio Inc | IBRX:US | Health Care | $166M | - | $11.1B |
| 44 | Repligen Corporation | RGEN:US | Health Care | $785M | 236.3 | $11.0B |
| 45 | Madrigal Pharmaceuticals Inc | MDGL:US | Health Care | $1.3B | - | $10.9B |
| 46 | Biomarin Pharmaceutical Inc | BMRN:US | Health Care | $3.4B | 148.1 | $10.6B |
| 47 | The Cooper Companies, Inc | COO:US | Health Care | $4.2B | 18.7 | $10.3B |
| 48 | The Ensign Group Inc | ENSG:US | Health Care | $5.5B | 27.3 | $10.1B |
| 49 | Twist Bioscience Corp | TWST:US | Health Care | $432M | - | $10.1B |
| 50 | Align Technology Inc | ALGN:US | Health Care | $4.1B | 24.4 | $10.0B |
| 51 | Krystal Biotech Inc | KRYS:US | Health Care | $440M | 41.6 | $9.8B |
| 52 | 10X Genomics Inc | TXG:US | Health Care | $617M | - | $9.8B |
| 53 | Insulet Corporation | PODD:US | Health Care | $3.1B | 26.2 | $9.7B |
| 54 | Henry Schein Inc | HSIC:US | Health Care | $13.6B | 24.5 | $9.6B |
| 55 | Kymera Therapeutics Inc | KYMR:US | Health Care | $105M | - | $9.3B |
| 56 | Protagonist Therapeutics Inc | PTGX:US | Health Care | $282M | 139.5 | $9.3B |
| 57 | Bruker Corporation | BRKR:US | Health Care | $3.5B | - | $9.0B |
| 58 | Bausch + Lomb Corp | BLCO:TO | Health Care | $5.3B | - | $8.8B |
| 59 | Axsome Therapeutics Inc | AXSM:US | Health Care | $777M | - | $8.8B |
| 60 | Cytokinetics Inc | CYTK:US | Health Care | $68M | - | $8.7B |
| 61 | Arrowhead Pharmaceuticals Inc | ARWR:US | Health Care | $669M | - | $8.6B |
| 62 | TG Therapeutics Inc | TGTX:US | Health Care | $800M | 20.1 | $8.5B |
| 63 | Caris Life Sciences, Inc. Common Stock | CAI:US | Health Care | $990M | 17.6 | $8.4B |
| 64 | Spyre Therapeutics Inc. | SYRE:US | Health Care | - | - | $8.0B |
| 65 | Abivax SA American Depositary Shares | ABVX:US | Health Care | $5M | - | $7.7B |
| 66 | HealthEquity Inc | HQY:US | Health Care | $1.4B | 33.4 | $7.7B |
| 67 | Ionis Pharmaceuticals Inc | IONS:US | Health Care | $874M | - | $7.5B |
| 68 | Praxis Precision Medicines Inc | PRAX:US | Health Care | $7M | - | $7.3B |
| 69 | Amneal Pharmaceuticals, Inc. Class A Common Stock | AMRX:US | Health Care | $3.1B | 40.9 | $7.0B |
| 70 | Alkermes Plc | ALKS:US | Health Care | $1.7B | 105.9 | $6.8B |
| 71 | Iovance Biotherapeutics Inc | IOVA:US | Health Care | $325M | - | $6.6B |
| 72 | Lantheus Holdings Inc | LNTH:US | Health Care | $1.6B | 24.2 | $6.5B |
| 73 | Rhythm Pharmaceuticals Inc | RYTM:US | Health Care | $240M | - | $6.3B |
| 74 | Kodiak Sciences Inc | KOD:US | Health Care | - | - | $6.2B |
| 75 | Belite Bio Inc ADR | BLTE:US | Health Care | - | - | $6.2B |
| 76 | GRAIL, LLC | GRAL:US | Health Care | $165M | - | $6.1B |
| 77 | Kiniksa Pharmaceuticals Ltd | KNSA:US | Health Care | $841M | 80.0 | $6.1B |
| 78 | Immunovant Inc | IMVT:US | Health Care | - | - | $6.1B |
| 79 | Ligand Pharmaceuticals Incorporated | LGND:US | Health Care | $291M | 31.8 | $6.0B |
| 80 | CG Oncology, Inc. Common stock | CGON:US | Health Care | $6M | - | $5.7B |
| 81 | Erasca Inc | ERAS:US | Health Care | - | - | $5.6B |
| 82 | Mirum Pharmaceuticals Inc | MIRM:US | Health Care | $618M | - | $5.6B |
| 83 | RadNet Inc | RDNT:US | Health Care | $2.3B | - | $5.6B |
| 84 | MiniMed Group, Inc. Common Stock | MMED:US | Health Care | $3.2B | - | $5.5B |
| 85 | Cogent Biosciences Inc | COGT:US | Health Care | - | - | $5.4B |
| 86 | Oruka Therapeutics, Inc. | ORKA:US | Health Care | - | - | $5.3B |
| 87 | PTC Therapeutics Inc | PTCT:US | Health Care | $1.0B | - | $5.3B |
| 88 | Merit Medical Systems Inc | MMSI:US | Health Care | $1.6B | 35.9 | $5.2B |
| 89 | Crispr Therapeutics AG | CRSP:US | Health Care | $13M | - | $5.2B |
| 90 | Sotera Health Co | SHC:US | Health Care | $1.2B | 31.7 | $5.2B |
| 91 | Waystar Holding Corp. Common Stock | WAY:US | Health Care | $1.2B | 38.1 | $5.1B |
| 92 | Scholar Rock Holding Corp | SRRK:US | Health Care | - | - | $5.1B |
| 93 | Grifols SA ADR | GRFS:US | Health Care | $7.4B | 9.7 | $5.1B |
| 94 | Definium Therapeutics, Inc. | DFTX:US | Health Care | - | - | $5.0B |
| 95 | Travere Therapeutics Inc | TVTX:US | Health Care | $591M | - | $4.9B |
| 96 | Lifestance Health Group Inc | LFST:US | Health Care | $1.6B | 95.5 | $4.7B |
| 97 | Option Care Health Inc | OPCH:US | Health Care | $5.7B | 23.5 | $4.7B |
| 98 | BillionToOne, Inc. Class A Common Stock | BLLN:US | Health Care | $397M | 155.7 | $4.6B |
| 99 | Dianthus Therapeutics Inc. | DNTH:US | Health Care | $2M | - | $4.5B |
| 100 | Heartflow, Inc. Common Stock | HTFL:US | Health Care | $212M | - | $4.3B |
| 101 | Indivior PLC Ordinary Shares | INDV:US | Health Care | $1.3B | 12.9 | $4.3B |
| 102 | Edgewise Therapeutics Inc | EWTX:US | Health Care | - | - | $4.2B |
| 103 | Adaptive Biotechnologies Corp | ADPT:US | Health Care | $308M | - | $4.2B |
| 104 | LivaNova PLC | LIVN:US | Health Care | $1.5B | 22.6 | $4.2B |
| 105 | Abcellera Biologics Inc | ABCL:US | Health Care | $66M | - | $4.1B |
| 106 | Tango Therapeutics Inc | TNGX:US | Health Care | $54M | - | $4.0B |
| 107 | ICU Medical Inc | ICUI:US | Health Care | $2.2B | 134.7 | $4.0B |
| 108 | CorVel Corp | CRVL:US | Health Care | $984M | 34.8 | $3.9B |
| 109 | Relay Therapeutics Inc | RLAY:US | Health Care | $10M | - | $3.9B |
| 110 | Pulse Biosciences Inc | PLSE:US | Health Care | $1M | - | $3.8B |
| 111 | Telix Pharmaceuticals Limited | TLX:US | Health Care | $891M | 112.1 | $3.8B |
| 112 | Regencell Bioscience Holdings Ltd | RGC:US | Health Care | - | - | $3.6B |
| 113 | Viking Therapeutics Inc | VKTX:US | Health Care | - | - | $3.6B |
| 114 | Legend Biotech Corp | LEGN:US | Health Care | $1.3B | - | $3.6B |
| 115 | Veracyte Inc | VCYT:US | Health Care | $562M | 31.4 | $3.5B |
| 116 | Amylyx Pharmaceuticals Inc | AMLX:US | Health Care | $-665,000 | - | $3.5B |
| 117 | Xenon Pharmaceuticals Inc | XENE:US | Health Care | - | - | $3.5B |
| 118 | iRhythm Technologies Inc | IRTC:US | Health Care | $825M | - | $3.5B |
| 119 | Ideaya Biosciences Inc | IDYA:US | Health Care | $234M | - | $3.5B |
| 120 | Tarsus Pharmaceuticals Inc | TARS:US | Health Care | $606M | - | $3.4B |
| 121 | ACADIA Pharmaceuticals Inc | ACAD:US | Health Care | $1.1B | 8.9 | $3.4B |
| 122 | Parabilis Medicines, Inc. Common Stock | PBLS:US | Health Care | $148,000 | - | $3.4B |
| 123 | Arcutis Biotherapeutics Inc | ARQT:US | Health Care | $464M | 120.8 | $3.3B |
| 124 | Celcuity LLC | CELC:US | Health Care | - | - | $3.3B |
| 125 | CareDx Inc | CDNA:US | Health Care | $458M | 30.6 | $3.3B |
| 126 | Bausch Health Companies Inc | BHC:TO | Health Care | $10.9B | - | $3.2B |
| 127 | Denali Therapeutics Inc | DNLI:US | Health Care | $4M | - | $3.0B |
| 128 | Enliven Therapeutics Inc. | ELVN:US | Health Care | - | - | $3.0B |
| 129 | Dyne Therapeutics Inc | DYN:US | Health Care | - | - | $3.0B |
| 130 | AtriCure Inc | ATRC:US | Health Care | $570M | 272.8 | $2.9B |
| 131 | Zai Lab Ltd | ZLAB:US | Health Care | $450M | - | $2.8B |
| 132 | Acadia Healthcare Company Inc | ACHC:US | Health Care | $3.4B | - | $2.8B |
| 133 | Maravai Lifesciences Holdings Inc | MRVI:US | Health Care | $209M | - | $2.8B |
| 134 | Precigen Inc | PGEN:US | Health Care | $86M | - | $2.7B |
| 135 | ATAI Life Sciences BV | ATAI:US | Health Care | $4M | - | $2.7B |
| 136 | TransMedics Group Inc | TMDX:US | Health Care | $668M | 20.3 | $2.7B |
| 137 | Aveanna Healthcare Holdings Inc | AVAH:US | Health Care | $2.6B | 9.7 | $2.7B |
| 138 | Privia Health Group Inc | PRVA:US | Health Care | $2.4B | 99.3 | $2.7B |
| 139 | Beam Therapeutics Inc | BEAM:US | Health Care | $156M | - | $2.7B |
| 140 | Neogen Corporation | NEOG:US | Health Care | $884M | - | $2.6B |
| 141 | MBX Biosciences, Inc. Common Stock | MBX:US | Health Care | - | - | $2.6B |
| 142 | Clover Health Investments Corp | CLOV:US | Health Care | $2.5B | - | $2.5B |
| 143 | Extendicare Inc | EXE:TO | Health Care | $2.0B | 20.0 | $2.5B |
| 144 | Supernus Pharmaceuticals Inc | SUPN:US | Health Care | $830M | - | $2.5B |
| 145 | NewAmsterdam Pharma Company N.V. Ordinary Shares | NAMS:US | Health Care | $7M | - | $2.5B |
| 146 | Liquidia Technologies Inc | LQDA:US | Health Care | $451M | 19.9 | $2.5B |
| 147 | HUTCHMED DRC | HCM:US | Health Care | $549M | 141.0 | $2.5B |
| 148 | Sellas Life Sciences Group Inc | SLS:US | Health Care | - | - | $2.4B |
| 149 | Harmony Biosciences Holdings | HRMY:US | Health Care | $960M | 13.0 | $2.3B |
| 150 | Recursion Pharmaceuticals Inc | RXRX:US | Health Care | $55M | - | $2.3B |
| 151 | Disc Medicine Inc. | IRON:US | Health Care | - | - | $2.3B |
| 152 | Nurix Therapeutics Inc | NRIX:US | Health Care | $37M | - | $2.3B |
| 153 | Celldex Therapeutics Inc | CLDX:US | Health Care | $158,000 | - | $2.3B |
| 154 | Immunome Inc | IMNM:US | Health Care | - | - | $2.3B |
| 155 | ADMA Biologics Inc | ADMA:US | Health Care | $512M | 14.5 | $2.3B |
| 156 | UFP Technologies Inc | UFPT:US | Health Care | $632M | 31.2 | $2.2B |
| 157 | Aurinia Pharmaceuticals Inc | AUPH:US | Health Care | $312M | 7.3 | $2.2B |
| 158 | BioCryst Pharmaceuticals Inc | BCRX:US | Health Care | $941M | - | $2.2B |
| 159 | Pharvaris BV | PHVS:US | Health Care | - | - | $2.2B |
| 160 | Addus HomeCare Corporation | ADUS:US | Health Care | $1.5B | 20.2 | $2.2B |
| 161 | Progyny Inc | PGNY:US | Health Care | $1.3B | 30.5 | $2.2B |
| 162 | Sienna Senior Living Inc | SIA:TO | Health Care | $1.1B | 36.4 | $2.1B |
| 163 | Axogen Inc | AXGN:US | Health Care | $251M | - | $2.1B |
| 164 | Viridian Therapeutics Inc | VRDN:US | Health Care | $71M | - | $2.1B |
| 165 | Novavax Inc | NVAX:US | Health Care | $414M | - | $2.1B |
| 166 | NeoGenomics Inc | NEO:US | Health Care | $766M | - | $2.1B |
| 167 | Alvotech | ALVO:US | Health Care | $495M | - | $2.1B |
| 168 | Vericel Corp Ord | VCEL:US | Health Care | $306M | 85.3 | $2.1B |
| 169 | Schrodinger Inc | SDGR:US | Health Care | $259M | - | $2.0B |
| 170 | Palvella Therapeutics, Inc | PVLA:US | Health Care | - | - | $2.0B |
| 171 | Vera Therapeutics Inc | VERA:US | Health Care | - | - | $2.0B |
| 172 | Fortrea Holdings Inc. | FTRE:US | Health Care | $2.7B | - | $2.0B |
| 173 | Vir Biotechnology Inc | VIR:US | Health Care | $303M | - | $2.0B |
| 174 | Mineralys Therapeutics, Inc. Common Stock | MLYS:US | Health Care | - | - | $2.0B |
| 175 | Lakefront Biotherapeutics NV | LKFT:US | Health Care | $991M | 2.8 | $1.9B |
| 176 | Xeris Pharmaceuticals Inc | XERS:US | Health Care | $335M | - | $1.9B |
| 177 | GeneDx Holdings Corp. | WGS:US | Health Care | $454M | - | $1.9B |
| 178 | Agios Pharm | AGIO:US | Health Care | $98M | - | $1.9B |
| 179 | BioLife Solutions Inc | BLFS:US | Health Care | $107M | 39.0 | $1.9B |
| 180 | Sarepta Therapeutics Inc | SRPT:US | Health Care | $2.0B | - | $1.9B |
| 181 | Astrana Health Inc | ASTH:US | Health Care | $3.8B | 45.2 | $1.9B |
| 182 | Xencor Inc | XNCR:US | Health Care | $105M | - | $1.9B |
| 183 | Mesoblast Ltd | MESO:US | Health Care | $120M | - | $1.9B |
| 184 | Zymeworks Inc. Common Stock | ZYME:US | Health Care | $37M | - | $1.9B |
| 185 | LeMaitre Vascular Inc | LMAT:US | Health Care | $262M | 28.3 | $1.8B |
| 186 | Trevi Therapeutics Inc | TRVI:US | Health Care | - | - | $1.8B |
| 187 | Generate Biomedicines, Inc. Common Stock | GENB:US | Health Care | $26M | - | $1.8B |
| 188 | Establishment Labs Holdings Inc | ESTA:US | Health Care | $246M | - | $1.8B |
| 189 | Intellia Therapeutics Inc | NTLA:US | Health Care | $60M | - | $1.8B |
| 190 | Surgery Partners Inc | SGRY:US | Health Care | $3.4B | - | $1.8B |
| 191 | UroGen Pharma Ltd | URGN:US | Health Care | $189M | - | $1.8B |
| 192 | Septerna, Inc. Common Stock | SEPN:US | Health Care | $99M | - | $1.8B |
| 193 | Dentsply Sirona Inc | XRAY:US | Health Care | $3.6B | - | $1.8B |
| 194 | Alamar Biosciences, Inc. Common Stock | ALMR:US | Health Care | $100M | - | $1.8B |
| 195 | Absci Corp | ABSI:US | Health Care | $2M | - | $1.7B |
| 196 | Alphatec Holdings Inc | ATEC:US | Health Care | $815M | - | $1.7B |
| 197 | Zenas BioPharma, Inc. Common Stock | ZBIO:US | Health Care | $1M | - | $1.7B |
| 198 | Personalis Inc | PSNL:US | Health Care | $70M | - | $1.7B |
| 199 | Structure Therapeutics Inc. American Depositary Shares | GPCR:US | Health Care | - | - | $1.7B |
| 200 | Cronos Group Inc | CRON:TO | Health Care | $179M | 17.8 | $1.7B |